No description yet.
Vancouver, British Columbia, Canada
1 source · checked 3 times, last 2h ago
The filing reports $6,499,999 USD sold; $13,464,278 USD is the total offering amount and is not treated as money raised in this round.; not on the page it cites, so not applied: date
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Form D (equity, options, securities to be acquired) | $6.5M | 2026-11-06 | not stated | No recent discussion |
1 source · checked 3 times, last 2h ago [ VERIFIED ] read against 1 source The filing reports $6,499,999 USD sold; $13,464,278 USD is the total offering amount and is not treated as money raised in this round.; not on the page it cites, so not applied: date [ BUILT WITH ]·[ SEARCH ]from a Form D filing·[ SCRAPE ]1 page read: sec.gov·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Offering | $250,000 | 2025-04-29 | not stated | |
| Offering | $895,000 | 2025-03-14 | not stated | |
| Offering | $1,700,000 | 2025-02-06 | not stated | |
Vesalius Longevity Labs connects licensed healthcare providers with participating pharmacies so patients can receive patient-specific peptide prescriptions.
Checked against 13 sources yesterday
None named.